Published in Haemophilia on March 01, 2009
ATHN 11: Liver Transplantation Outcomes Study (HOT) | NCT04055051
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology (2009) 1.11
The 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans. Infect Chemother (2015) 1.07
Renal transplantation in patients with HIV. Nat Rev Nephrol (2009) 0.92
The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. BMC Infect Dis (2010) 0.89
Epidemiological implications of HIV-hepatitis C co-infection in South and Southeast Asia. Curr HIV/AIDS Rep (2014) 0.85
Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia. Haemophilia (2010) 0.81
Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and design. AIDS Res Treat (2015) 0.80
The 2013 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans. Infect Chemother (2013) 0.79
Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection. Biomaterials (2013) 0.79
Initiation of antiretroviral therapy. Indian J Sex Transm Dis (2014) 0.76
Liver transplant outcomes in HIV+ haemophilic men. Haemophilia (2012) 0.75
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet (2003) 4.88
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis (2001) 4.72
Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS (2005) 2.34
Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology (2001) 2.29
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis (2003) 2.17
End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood (2002) 1.73
Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C virus-coinfected patients? Clin Infect Dis (2005) 1.66
Hepatitis and clotting-factor concentrates. JAMA (1972) 1.44
Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol (2005) 1.44
Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis (2001) 1.30
Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2005) 1.28
The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection. Hepatology (2005) 1.17
Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol (1996) 1.10
Liver injury during highly active antiretroviral therapy: the effect of hepatitis C coinfection. Clin Infect Dis (2004) 0.97
Hepatitis C Virus in the HIV-infected patient. Clin Liver Dis (2006) 0.97
Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy. J Infect Dis (1999) 0.96
Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection. J Antimicrob Chemother (2003) 0.94
HAART attenuates liver fibrosis in patients with HIV/HCV co-infection: fact or fiction? J Antimicrob Chemother (2006) 0.86
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol (1994) 2.68
Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet (1986) 2.07
Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci U S A (1998) 2.02
Identification of bipotential progenitor cells in human liver development. Hepatology (1996) 1.84
Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci U S A (1994) 1.76
Casein kinase II phosphorylates the eukaryote-specific C-terminal domain of topoisomerase II in vivo. EMBO J (1992) 1.76
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation (1999) 1.70
Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol (1980) 1.64
Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol (2012) 1.62
Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol (2000) 1.56
Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53
Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol (1993) 1.33
A fresh look at augmenter of liver regeneration in rats. Hepatology (1999) 1.32
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28
Identification of bipotential progenitor cells in human liver regeneration. Lab Invest (1996) 1.26
Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol (1995) 1.25
Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol (1997) 1.22
Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood (1988) 1.19
Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol (2001) 1.18
An update on donor-derived disease transmission in organ transplantation. Am J Transplant (2011) 1.15
Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol (1995) 1.15
Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit (1987) 1.12
Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut (2003) 1.12
Recurrent restenosis following stent and rotational atherectomy of coronary artery stenosis in Takayasu's arteritis. Int J Cardiol (1998) 1.10
Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology (1997) 1.08
FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology (1991) 1.05
Studies of an 800-kilobase DNA stretch of the Drosophila X chromosome: comapping of a subclass of scaffold-attached regions with sequences able to replicate autonomously in Saccharomyces cerevisiae. Mol Cell Biol (1990) 1.02
Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. Mod Pathol (1995) 1.02
Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients. Clin Cancer Res (2001) 1.01
Oxygen free radical content and neutrophil infiltration are important determinants in mucosal injury after rat small bowel transplantation. Transplantation (1996) 0.99
Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am J Transplant (2006) 0.99
Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol (1989) 0.99
Causes of death in autopsied liver transplantation patients. Mod Pathol (1998) 0.98
Characterization of ductular hepatocytes in primary liver allograft failure. Mod Pathol (1997) 0.97
In situ hybridization of albumin mRNA in normal liver and liver tumors: identification of hepatocellular origin. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 0.96
Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation. AJR Am J Roentgenol (2000) 0.96
Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes--an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis. J Hepatol (2000) 0.96
Ex vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigs. Am J Transplant (2010) 0.91
Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation (2002) 0.91
De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis. Liver Transpl Surg (1999) 0.91
Microchimerism, GVHD, and tolerance in solid organ transplantation. Transfusion (2001) 0.91
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol (2004) 0.91
Topoisomerase II forms multimers in vitro: effects of metals, beta-glycerophosphate, and phosphorylation of its C-terminal domain. Mol Cell Biol (1994) 0.90
Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies. Am J Kidney Dis (1994) 0.90
Genotypic analyses of cyclosporine-associated lymphoproliferations. Transplantation (1987) 0.90
A novel, fully implantable, multichannel biotelemetry system for measurement of blood flow, pressure, ECG, and temperature. J Appl Physiol (1985) (2006) 0.88
Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring? Am J Transplant (2011) 0.88
Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals. Transplantation (2000) 0.86
Primary pleural effusion posttransplant lymphoproliferative disorder: Distinction from secondary involvement and effusion lymphoma. Diagn Cytopathol (2001) 0.86
Detection of infectious baboon cytomegalovirus after baboon-to-human liver xenotransplantation. J Virol (2001) 0.86
Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol (1996) 0.85
Sequential analyses of the development of lymphoproliferative disorders in rats receiving cyclosporine. Transplantation (1984) 0.85
Spindle cell tumor of the portal vein. J Surg Oncol (1995) 0.84
Communication gaps associated with donor-derived infections. Am J Transplant (2014) 0.83
ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. Autoimmunity (1993) 0.83
Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis (1988) 0.83
Concomitant and isolated expression of TGF-alpha and EGF-R in human hepatoma cells supports the hypothesis of autocrine, paracrine, and endocrine growth of human hepatoma. J Surg Oncol (1995) 0.83
Alloimmune hepatitis following peripheral stem cell transplantation. Bone Marrow Transplant (2007) 0.83
Hepatocyte growth factor mRNA in human liver cirrhosis as evidenced by in situ hybridization. Scand J Gastroenterol (1996) 0.81
Effect of FK 506 on spontaneous diabetes in BB rats. Diabetes (1990) 0.81
Herpesvirus 6 variant A infection after heart transplantation with giant cell transformation in bile ductular and gastroduodenal epithelium. Am J Surg Pathol (1997) 0.81
Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia. Haemophilia (2010) 0.81
Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice. Clin Exp Immunol (1995) 0.79
Primary lymphadenopathic Kaposi's sarcoma in an immunocompetent 23-year-old man. Am J Clin Pathol (1986) 0.79
Reversal of graft-versus-host disease with infusion of autologous bone marrow. Cell Transplant (1994) 0.79
The potential role of cytokines in the pathogenesis of Epstein-Barr virus associated post-transplant lymphoproliferative disease. Leuk Lymphoma (1994) 0.78
Cancers among US organ donors: a comparison of transplant and cancer registry diagnoses. Am J Transplant (2014) 0.78
Clonal and morphological variation in a posttransplant lymphoproliferative disorder: evolution from clonal T-cell to clonal B-cell predominance. Hum Pathol (1998) 0.78
FK 506 inhibits cytokine gene and adhesion molecule expression in psoriatic skin lesions. Ann N Y Acad Sci (1993) 0.77
Decreased mucosal IgA levels in ileum of patients with chronic ulcerative colitis. Dig Dis Sci (1995) 0.77
Topoisomerase II: its functions and phosphorylation. Antonie Van Leeuwenhoek (1992) 0.77
Suppression of autoimmune thyroid disease by FK 506: influence on thyroid-infiltrating cells, adhesion molecule expression and anti-thyroglobulin antibody production. Clin Exp Immunol (1993) 0.77
Cross-species graft-versus-host-disease is accompanied by a donor-derived cellular immune response. Transplantation (1993) 0.76
Evidence that small bowel preservation causes primarily basement membrane and endothelial rather than epithelial cell injury. Transplantation (1993) 0.76
Lymphoepithelial carcinoma of the larynx and hypopharynx: study of eight cases with relationship to Epstein-Barr virus and p53 gene alterations, and review of the literature. Hum Pathol (1996) 0.76
Epstein-Barr virus-encoded RNA expression as a risk factor for the development of posttransplantation lymphoproliferative disease. Hepatology (1995) 0.75
Posttransplant lymphoproliferative disease of donor origin. Arch Pathol Lab Med (1997) 0.75
FK 506 modulates D-galactosamine-induced hepatitis in rats. Transplant Proc (1991) 0.75
Quantitative analysis of microchimerism with Y-chromosome-specific PCR in canine small bowel transplantation. Transplant Proc (2000) 0.75
Long-term function and morphology of intestinal allografts in outbred canine transplantation model. Transplant Proc (2002) 0.75
Immunodulation of intestinal transplantation: antilymphocyte serum donor pretreatment vs. ex vivo graft irradiation. Transplant Proc (2002) 0.75
Small bowel preservation causes basement membrane and endothelial cell injury. Transplant Proc (1994) 0.75
The surgical implications of the posttransplant lymphoproliferative disorders. Transplant Proc (1991) 0.75
Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease. Transplantation (1998) 0.75
Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. Transplant Proc (1995) 0.75
A comparison of indirect immunofluorescence and the avidin-biotin-peroxidase conjugate technic (ABC) in the performance of the antinuclear antibody test. Am J Clin Pathol (1984) 0.75
Extramedullary hematopoiesis in the allograft liver. Mod Pathol (1995) 0.75
[Prevention of blindness in rural areas of north China during the past 30 years (author's transl)]. Zhonghua Yan Ke Za Zhi (1980) 0.75
Oxygen free radical formation is related to mucosal injury during reperfusion after rat small bowel transplantation. Transplant Proc (1994) 0.75
Occult nonhematopoietic malignancies present at autopsy in solid organ transplant patients who died within 100 days. Transplantation (2001) 0.75
Renal cortical neoplasms in long term survivors of solid organ transplantation. Transplantation (2000) 0.75
Expression of HGF mRNA in human rejecting kidney as evidenced by in situ hybridization. Urol Res (1996) 0.75
Quantitative assessment of the development of hepatoma in a buffalo rat model. Transplant Proc (1997) 0.75
Cytologic features of post-transplant lymphoproliferative disorder. Diagn Cytopathol (1997) 0.75
Intracranial lipoma with hematopoietic elements (myelolipoma): report of a case with successful surgical resection. Cancer (1982) 0.75